
|Videos|November 10, 2022
Institutional Perspectives in Neurology, Chaired by Robert T. Naismith, MD
Author(s)NeurologyLive® Staff
Chaired by Robert T. Naismith, MD, of Washington University in St. Louis, the presentations also feature Salim Chahin, MD, MSCE; Anne H. Cross, MD; Gregory F. Wu, MD, PhD; and Matthew R. Brier, MD, PhD. [WATCH TIME: 1 hour, 55 minutes]
Advertisement
NeurologyLive® State of the Science events are short meetings designed to educate neurologists and APPs on the clinical benefits associated with the new science driving new thinking. Our renowned faculty focuses on the most relevant topics to ultimately improve patient care.
TOPICS INCLUDE:
- 02:45 – ECTRIMS Case Presentation: Evidence-Based MS Care — Robert T. Naismith, MD
- 17:25 – Pro: Epstein-Barr Virus Causes Multiple Sclerosis — Anne H. Cross, MD
- 38:30 – Con: Epstein-Barr Virus Causes Multiple Sclerosis — Gregory F. Wu, MD, PhD
- 56:20 – Question & Answer
- 1:08:10 – Choosing a DMT — Salim Chahin, MD, MSCE
- 1:23:55 – Clinical Neuroimaging in MS: More Than Counting Lesions — Matthew R. Brier, MD, PhD
- 1:39:55 – Question & Answer
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis
2
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
3
Using Human iPSC Models to Dissect PIRA Mechanisms in Progressive Multiple Sclerosis: Valentina Fossati, PhD
4
Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis
5










